New strategies for the treatment of breast cancer with leptomeningeal metastasis

SM Chew, AD Seidman - Current Opinion in Oncology, 2023 - journals.lww.com
New strategies for the treatment of breast cancer with lepto... : Current Opinion in Oncology
New strategies for the treatment of breast cancer with leptomeningeal metastasis : Current …

Leptomeningeal metastases in breast cancer patients—current rules of diagnosis and treatment

A Niwińska, M Kunkiel - Oncology in Clinical Practice, 2016 - journals.viamedica.pl
Leptomeningeal metastases (LM) presents a challenge because of the difficulty in
determining the diagnosis and lack of optimal therapy. Nowadays, LM are more frequently …

Pharmacotherapy for leptomeningeal disease in breast cancer

R Bartsch, KJ Jerzak, L Larrouquere, V Müller… - Cancer Treatment …, 2023 - Elsevier
Clinical data supporting the best therapeutic approach in leptomeningeal disease (LMD;
also known as leptomeningeal metastases or leptomeningeal carcinomatosis) are lacking …

Management of leptomeningeal metastasis in breast cancer

HI Assi, T Mahmoud, FS Saadeh, H El Darsa - Clinical neurology and …, 2018 - Elsevier
Leptomeningeal metastasis (LM), which occurs when malignant cells spread to the central
nervous system, is becoming an increasingly common complication in patients with breast …

Treatment of leptomeningeal carcinomatosis: current challenges and future opportunities

M Kak, R Nanda, EE Ramsdale, RV Lukas - Journal of Clinical …, 2015 - Elsevier
Leptomeningeal metastasis (LM) in breast cancer patients confers a uniformly poor
prognosis and decreased quality of life. Treatment options are limited and often ineffective …

Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: a single-centre experience

B Kingston, H Kayhanian, C Brooks, N Cox… - The Breast, 2017 - Elsevier
Purpose Leptomeningeal disease (LMD) is an uncommon complication of advanced breast
cancer. The prognosis is poor, and although radiotherapy (RT), systemic and intra-thecal (IT) …

[HTML][HTML] Leptomeningeal metastasis in breast cancer–a systematic review

BJ Scott, NA Oberheim-Bush, S Kesari - Oncotarget, 2016 - ncbi.nlm.nih.gov
Background There is limited data on the impact of specific patient characteristics, tumor
subtypes or treatment interventions on survival in breast cancer LM. Methods A systematic …

Breast cancer leptomeningeal metastasis—the role of multimodality treatment

H Rudnicka, A Niwińska, M Murawska - Journal of neuro-oncology, 2007 - Springer
Aim The aim of the study was to assess the efficacy of multimodality treatment of patients
with Leptomeningeal metastasis (LM) and to establish which method of treatment has the …

Prolonged survival of patients with breast cancer-related leptomeningeal metastases

E Le Rhun, S Taillibert, F Zairi, D Pannier… - Anticancer …, 2013 - ar.iiarjournals.org
Background/Aim: Prolonged overall survival (OS) has been reported for selected patients
with leptomeningeal metastases (LM). The management and treatment of such patients is …

CNS metastasis in primary breast cancer

M Sharma, J Abraham - Expert Review of Anticancer Therapy, 2007 - Taylor & Francis
The development of CNS metastasis in patients with solid malignancies represents a turning
point in the disease process. The prevalence of CNS metastasis from breast cancer may be …